Hong Kong IPO disclosure precedents · 257 companies, 267 items
most revenue from one product, project, site, business line or region (e.g. a single mine, a single drug, one flagship product, projects and customers concentrated in one province)
During the Track Record Period, substantially all of our revenue was derived from the sales of Human TAT.
Summary · p. 6
We are the largest provider and exporter of human tetanus antitoxins (‘‘Human TAT’’), in China.
Summary · p. 1
In addition, our diversified pipeline is focused on advancing products in high-growth therapeutic areas and meeting unmet medical needs to drive future growth.
We are primarily engaged in the R&D, manufacturing, and sales of vehicle smart imaging devices for automotive and travel scenarios, with dash cameras, which constitute our core type of vehicle smart imaging devices and are offered in a wide range of models under our DDPAI brand across different product series, being our major product category and the primary contributor to our revenue during the Track Record Period.
Business · p. 120
As dash cameras are our core product category, the impact of our pricing strategy is most directly reflected in the steady growth of our overall ASP of dash cameras, which increased from RMB252.2 per unit for the year ended December 31, 2023 to RMB261.4 per unit for the year ended December 31, 2024, and further to RMB303.9 per unit for the year ended December 31, 2025.
Our results of operations are significantly influenced by the market demand for caviar, our core product.
Financial Information · p. 188
Our strong reserve of sturgeon broodstock and juveniles ensures a stable and sustainable long-term supply while enabling swift responses to market demand fluctuations, thereby maintaining production continuity and supply flexibility.
Our revenue generated from sales of harmonic reducers and other components amounted to RMB92.5 million, RMB103.4 million and RMB167.1 million, accounting for 97.8%, 96.0% and 64.1% of our total revenue in the same respective periods.
Business · p. 160
Our business expansion during the Track Record Period was primarily driven by the production and sales of our harmonic reducers, and joint modules and robotic arms.
Business · p. 160
Our joint modules and robotic arms, and automated workstations, which commenced revenue generation in 2023 and 2025, respectively, are at the relatively early stage of commercialization and are gradually contributing to our revenue growth.
Sales of functional ingredients and nutritional products accounted for 96.5%, 92.9%, and 86.1% of our total revenue in 2023, 2024 and 2025, respectively, and our revenue generated from this offering category was primarily in relation to sales of caffeine.
Financial Information · p. 208
Accordingly, the price volatility of caffeine is considered a major factor affecting our results of operations.
Financial Information · p. 208
While solidifying our leading position as a major caffeine supplier in food and beverage industries, we are actively seeking to expand our supply of caffeine in other downstream industries, such as pharmaceuticals, cosmetics and personal care, pet food, and health supplements.
In 2023, 2024 and 2025, revenue generated from restaurant operation related services was RMB2,044.9 million, RMB2,253.6 million and RMB2,804.4 million, respectively, representing 96.8%, 97.7% and 98.5% of our total revenue in the same periods, respectively.
Financial Information · p. 205
Therefore, our revenue and operational performance primarily rely on our ability to effectively expand the network of our restaurants nationwide.
Financial Information · p. 205
We plan to use cash generated from our operations and [REDACTED] from the [REDACTED] to support our expansion plan.
As a key example, as of the Latest Practicable Date, we operated 54 restaurants in Henan and 146 restaurants across other provinces in China, demonstrating our ability to replicate the success of our “Henan Model” in markets beyond our core region.
Our product portfolio primarily consists of (i) nickel-based products, (ii) copper-based products, (iii) silver powders, and (iv) alloy powders, with nickel-based products and copper-based products contributing a majority of our revenue.
Financial Information · p. 169
We believe our established technology platform, product quality, mass production capability and product portfolio covering high-end nickel powders, copper powders and silver-coated copper powders position us to capture growth opportunities arising from the continued development of consumer electronics, automotive electronics, industrial automation, AI, PV new energy, and semiconductor packaging industries.
In addition, our business in the electronic device segment contributed approximately 89.9%, 92.1% and 87.1% of our total revenue in 2023, 2024 and 2025, respectively.
Financial Information · p. 227
Given its scale and profitability, the electronic device segment is expected to remain our major revenue contributor, and changes in its performance are likely to have a significant impact on our overall profitability.
During the Track Record Period, we primarily derived our revenue from the sale of signal chain ICs and power management ICs.
Financial Information · p. 177
Our product mix may fluctuate in response to the technological changes in the industries and markets to which our products are sold, and the changes in market demand.
Financial Information · p. 177
We have engineered the most comprehensive analog and sensor portfolio in China, according to Frost & Sullivan, with over 7,200 products across 38 categories, providing our customers with distinctive breadth and depth to address complex design challenges across industries.
In FY2023, FY2024 and FY2025, our revenue was primarily derived from sales of admission tickets of our park and show tickets for the Reminiscences of the Eastern Capital, amounting to RMB584.9 million, RMB621.9 million and RMB621.9 million, respectively, accounting for 86.9%, 83.9% and 83.3% of our total revenue for the corresponding years.
Summary · p. 1
As such, our results of operations are affected by overall demand in China’s tourism industry, particularly in Henan Province and Kaifeng, as well as the growth of China’s theme park industry and our ability to maintain our market position.
Financial Information · p. 198
Our ability to maintain the reputation of Millennium City Park and to continue upgrading and expanding attractive Song-themed experiences within the Park may affect tourist visits, ticket sales and in-park spending, which could in turn affect our business, results of operations and financial performance.
A majority of our revenue is derived from the sales of robots integrating our SRC series robotic controllers, which have demonstrated a constant growth trend throughout the Track Record Period.
Summary · p. 4
While robots contributed a larger portion of our revenue due to their higher selling prices arising from the inclusion of mechanical structures and other physical components, revenue contribution alone may not fully reflect the breadth of deployment and technological value delivered through our robotic controllers.
Summary · p. 4
As a result, our revenue mix has an impact on our overall gross profit margin.
During the Track Record Period, we generated majority of our revenue from fees received from providing pharmacological efficacy and safety assessment services in connection with nonclinical studies.
Summary · p. 7
The gross profit margins for our nonclinical study services was higher than that for our clinical trial services as we possess core strengths in our nonclinical business, particularly in our research model portfolio.
Content licensing services contributed RMB575.2 million, RMB609.6 million and RMB523.7 million of revenue in 2023, 2024 and 2025, respectively, accounting for 73.7%, 75.1% and 67.2% of our total revenue in the same respective years.
Financial Information · p. 159
While continuing to strengthen our content licensing business, we have accelerated the expansion of content customization services and value-added services, aiming to capture opportunities arising from the ongoing transformation of the content services industry.
During the Track Record Period, our revenue is primarily derived from the sales of AiTruck.
Business · p. 139
In particular, the decrease and subsequent increase in revenue from our logistics customers in 2024 and 2025, respectively, was mainly attributable to the changing contribution of our Trunk Pilot business, which recorded revenue of RMB42.1 million in 2024 and RMB215.2 million in 2025.
Business · p. 157
The increase and subsequent decrease in revenue from our hub operation customers in 2024 and 2025, respectively, primarily reflected the delivery and revenue recognition timing of major projects in our Trunk Port business, which recorded revenue of RMB181.9 million in 2024 and RMB127.5 million in 2025.
During the Track Record Period, majority of our revenue was generated from our overseas marketing services, accounting for approximately 99.3%, 99.3% and 93.1% of our total revenue for the years ended December 31, 2023, 2024 and 2025, respectively.
Summary · p. 4
We expect that our overseas e-commerce operation business segment will continue to grow and contribute to our future profitability.
We derived substantially all of our revenue from the sales of our lithium-ion battery separators during the Track Record Period.
Business · p. 144
During the Track Record Period, all of our revenue was derived from the sales of lithium-ion battery separators, including dry process separators, wet process separators and coated separators.
During the Track Record Period, our revenue is primarily driven by our electrolytic copper foil business, namely the lithium-ion battery copper foil and the electronic circuit copper foil.
Financial Information · p. 188
Looking forward, to further optimize our product matrix, we intend to continuously pursue multi-dimensional technological development, with a focus on expanding the contribution from higher value-added and higher-margin products.